Ropele S - Search Results

1

Total gray matter volume is reduced in individuals with bipolar disorder currently treated with atypical antipsychotics.

Birner A, Bengesser SA, Seiler S, Dalkner N, Queissner R, Platzer M, Fellendorf FT, Hamm C, Maget A, Pilz R, Lenger M, Reininghaus B, Pirpamer L, Ropele S, Hinteregger N, Magyar M, Deutschmann H, Enzinger C, Kapfhammer HP, Reininghaus EZ. Birner A, et al. Among authors: ropele s. J Affect Disord. 2020 Jan 1;260:722-727. doi: 10.1016/j.jad.2019.09.068. Epub 2019 Sep 19. J Affect Disord. 2020. PMID: 31563071

2

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis.

Fazekas F, Strasser-Fuchs S, Schmidt H, Enzinger C, Ropele S, Lechner A, Flooh E, Schmidt R, Hartung HP. Fazekas F, et al. Among authors: ropele s. J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):25-8. doi: 10.1136/jnnp.69.1.25. J Neurol Neurosurg Psychiatry. 2000. PMID: 10864599 Free PMC article.

3

A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis.

Ropele S, Strasser-Fuchs S, Augustin M, Stollberger R, Enzinger C, Hartung HP, Fazekas F. Ropele S, et al. AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1885-91. AJNR Am J Neuroradiol. 2000. PMID: 11110542 Free PMC article.

4

The natural course of MRI white matter hyperintensities.

Schmidt R, Schmidt H, Kapeller P, Enzinger C, Ropele S, Saurugg R, Fazekas F. Schmidt R, et al. Among authors: ropele s. J Neurol Sci. 2002 Nov 15;203-204:253-7. doi: 10.1016/s0022-510x(02)00300-3. J Neurol Sci. 2002. PMID: 12417393 Review.

5

Risk factors and progression of small vessel disease-related cerebral abnormalities.

Schmidt R, Fazekas F, Enzinger C, Ropele S, Kapeller P, Schmidt H. Schmidt R, et al. Among authors: ropele s. J Neural Transm Suppl. 2002;(62):47-52. doi: 10.1007/978-3-7091-6139-5_4. J Neural Transm Suppl. 2002. PMID: 12456049 Review.

6

Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis.

Fazekas F, Ropele S, Enzinger C, Seifert T, Strasser-Fuchs S. Fazekas F, et al. Among authors: ropele s. Mult Scler. 2002 Dec;8(6):479-84. doi: 10.1191/1352458502ms860oa. Mult Scler. 2002. PMID: 12474987 Clinical Trial.

7

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP, Fazekas F. Enzinger C, et al. Among authors: ropele s. Arch Neurol. 2003 Jan;60(1):65-70. doi: 10.1001/archneur.60.1.65. Arch Neurol. 2003. PMID: 12533090

8

Method for quantitative imaging of the macromolecular 1H fraction in tissues.

Ropele S, Seifert T, Enzinger C, Fazekas F. Ropele S, et al. Magn Reson Med. 2003 May;49(5):864-71. doi: 10.1002/mrm.10427. Magn Reson Med. 2003. PMID: 12704769 Free article.

9

Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study.

Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F; Austrian Stroke Prevention Study. Schmidt R, et al. Among authors: ropele s. Lancet. 2003 Jun 14;361(9374):2046-8. doi: 10.1016/s0140-6736(03)13616-1. Lancet. 2003. PMID: 12814718

10

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, Schmidt H, Matthews PM, Fazekas F. Enzinger C, et al. Among authors: ropele s. Ann Neurol. 2004 Apr;55(4):563-9. doi: 10.1002/ana.20027. Ann Neurol. 2004. PMID: 15048896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters